Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators
dc.contributor.author | Bridoux, Alexandre | |
dc.contributor.author | Cui, Huadong | |
dc.contributor.author | Dyskin, Evgeny | |
dc.contributor.author | Schmitzer, Andreea Ruxandra | |
dc.contributor.author | Mousa, Shaker A. | |
dc.contributor.buuauthor | Yalçın, Murat | |
dc.contributor.department | Uludağ Üniversitesi/Veterinerlik Fakültesi/Temel Bilimler Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-5600-8162 | tr_TR |
dc.contributor.researcherid | AAG-6956-2021 | tr_TR |
dc.contributor.scopusid | 57192959734 | tr_TR |
dc.date.accessioned | 2022-07-07T10:23:21Z | |
dc.date.available | 2022-07-07T10:23:21Z | |
dc.date.issued | 2010-06-01 | |
dc.description.abstract | Novel thyroxine analogs with hindered phenol, amino and carboxylic acid groups have been synthesized and the effects of the synthesized compounds on angiogenesis using the chick chorioallantoic membrane and mouse matrigel models have been tested. Pharmacological profiles revealed that thyroxine tolerates numerous modifications on the amino group and remains active. These results provide the rationale for the selection of a novel thyroxine nanoparticle precursor. | en_US |
dc.description.sponsorship | Charitable Leadership Foundation | en_US |
dc.description.sponsorship | Medical Technology Acceleration Program | en_US |
dc.description.sponsorship | Pharmaceutical Research Institute | en_US |
dc.identifier.citation | Bridoux, A. vd. (2010). "Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators". Bioorganic and Medicinal Chemistry Letters, 20(11), 3394-3398. | en_US |
dc.identifier.endpage | 3398 | tr_TR |
dc.identifier.issn | 0960-894X | |
dc.identifier.issn | 1464-3405 | |
dc.identifier.issue | 11 | tr_TR |
dc.identifier.pubmed | 20434332 | tr_TR |
dc.identifier.scopus | 2-s2.0-77953293160 | tr_TR |
dc.identifier.startpage | 3394 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2010.04.011 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0960894X10004713 | |
dc.identifier.uri | http://hdl.handle.net/11452/27789 | |
dc.identifier.volume | 20 | tr_TR |
dc.identifier.wos | 000277788900043 | tr_TR |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.journal | Bioorganic and Medicinal Chemistry Letters | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Thyroxine | en_US |
dc.subject | Esterification | en_US |
dc.subject | Silylation | en_US |
dc.subject | UV-vis | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | Nanopharmaceutical technology | en_US |
dc.subject | Extracelluler segment | en_US |
dc.subject | Crystal-structure | en_US |
dc.subject | Thyhroid-hormone | en_US |
dc.subject | Force-field | en_US |
dc.subject | Proteins | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Chemistry | en_US |
dc.subject.emtree | Amino acid | en_US |
dc.subject.emtree | Angiogenesis inhibitor | en_US |
dc.subject.emtree | Matrigel | en_US |
dc.subject.emtree | Thyroxine derivative | en_US |
dc.subject.emtree | Angiogenesis | en_US |
dc.subject.emtree | Animal experiment | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Chick | en_US |
dc.subject.emtree | Chorioallantois | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Drug activity | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Drug synthesis | en_US |
dc.subject.emtree | Drug tolerability | en_US |
dc.subject.emtree | Mouse | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.mesh | Angiogenesis inhibitors | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Chick embryo | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Models, molecular | en_US |
dc.subject.mesh | Thyroxine | en_US |
dc.subject.scopus | Tetraiodothyroacetic Acid; Thyroid Hormones; Nano-Diamino-Tetrac | en_US |
dc.subject.wos | Chemistry, medicinal | en_US |
dc.subject.wos | Chemistry, organic | en_US |
dc.title | Semisynthesis and pharmacological activities of thyroxine analogs: Development of new angiogenesis modulators | en_US |
dc.type | Article | |
dc.wos.quartile | Q2 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: